Zentalis Pharmaceuticals, Inc.
ZNTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$166 | -$292 | -$237 | -$166 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | -$1 | -$1 | -$3 |
| Stock-Based Comp. | $67 | $55 | $47 | $36 |
| Change in WC | -$17 | $6 | $13 | $17 |
| Other Non-Cash | -$57 | $23 | $13 | -$38 |
| Operating Cash Flow | -$171 | -$208 | -$164 | -$154 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$3 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | -$14 |
| Inv. Purchases | -$128 | -$549 | -$533 | -$364 |
| Inv. Sales/Matur. | $305 | $505 | $422 | $366 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | $177 | -$44 | -$114 | -$18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $237 | $261 | $180 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | $0 | -$1 |
| Financing Cash Flow | $0 | $237 | $261 | $179 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | -$15 | -$17 | $6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31 | $46 | $63 | $56 |
| End Cash | $37 | $31 | $46 | $63 |
| Free Cash Flow | -$171 | -$208 | -$166 | -$160 |